Secondary |
Product Used For Unknown Indication |
70.5% |
Drug Use For Unknown Indication |
10.1% |
Anxiety |
2.8% |
Insomnia |
2.7% |
Depression |
2.5% |
Psychotic Disorder |
1.5% |
Bipolar I Disorder |
1.3% |
Bone Marrow Conditioning Regimen |
1.1% |
Dementia With Lewy Bodies |
0.8% |
Schizoaffective Disorder |
0.8% |
Hallucination |
0.7% |
Hypertension |
0.7% |
Intentional Overdose |
0.7% |
Pain |
0.7% |
Prophylaxis |
0.7% |
Maternal Exposure During Pregnancy |
0.6% |
Alcoholism |
0.4% |
Bipolar Disorder |
0.4% |
Hepatitis C |
0.4% |
Pituitary-dependent Cushing's Syndrome |
0.4% |
|
Toxic Epidermal Necrolysis |
22.9% |
Rhabdomyolysis |
8.6% |
Fall |
7.1% |
Death |
5.7% |
Hypoglycaemia |
5.7% |
Cardio-respiratory Arrest |
4.3% |
Pancytopenia |
4.3% |
Sleep Disorder |
4.3% |
Transaminases Increased |
4.3% |
Weight Decreased |
4.3% |
Coma |
2.9% |
Confusional State |
2.9% |
Congenital Cystic Lung |
2.9% |
Intentional Overdose |
2.9% |
Neuroleptic Malignant Syndrome |
2.9% |
Neutropenia |
2.9% |
Normochromic Normocytic Anaemia |
2.9% |
Sudden Death |
2.9% |
Supraventricular Extrasystoles |
2.9% |
Vomiting |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
32.7% |
Drug Use For Unknown Indication |
16.1% |
Depression |
8.7% |
Insomnia |
8.2% |
Pain |
4.2% |
Hypertension |
4.2% |
Hepatitis C |
3.6% |
Anxiety |
3.0% |
Diarrhoea |
2.2% |
Hiv Infection |
2.0% |
Type 2 Diabetes Mellitus |
1.9% |
Rheumatoid Arthritis |
1.7% |
Bipolar Disorder |
1.6% |
Diffuse Large B-cell Lymphoma Recurrent |
1.6% |
Osteoporosis |
1.6% |
Bipolar I Disorder |
1.5% |
Crohn's Disease |
1.4% |
Hypothyroidism |
1.4% |
Psychotic Disorder |
1.4% |
Asthma |
1.3% |
|
Vomiting |
10.5% |
Renal Failure Acute |
7.6% |
Myocardial Infarction |
5.7% |
Neutropenia |
5.7% |
Pneumonia Aspiration |
5.7% |
Pulmonary Embolism |
5.7% |
Toxic Epidermal Necrolysis |
5.7% |
Rhabdomyolysis |
4.8% |
Somnolence |
4.8% |
Thrombophlebitis |
4.8% |
Tremor |
4.8% |
Acute Respiratory Distress Syndrome |
3.8% |
Anal Cancer |
3.8% |
Death |
3.8% |
Intestinal Obstruction |
3.8% |
Malaise |
3.8% |
Myoclonus |
3.8% |
Pulmonary Interstitial Emphysema Syndrome |
3.8% |
Sepsis |
3.8% |
Thrombocytopenia |
3.8% |
|
Interacting |
Drug Use For Unknown Indication |
33.3% |
Hypertension |
16.7% |
Product Used For Unknown Indication |
16.7% |
Schizophrenia |
16.7% |
Sleep Disorder |
8.3% |
Schizophrenia Simple |
4.2% |
Simple Schizophrenia |
4.2% |
|
General Physical Health Deterioration |
33.3% |
Somnolence |
33.3% |
Traumatic Shock |
33.3% |
|